OTC:CC - Ocumetics Begins to Manufacture Accommodating Intraocular Lenses for First-In-Human Study
(TheNewswire)
Calgary, Alberta – TheNewswire - July 22, 2024 - Ocumetics Technology Corp. (“ Ocumetics ” or the“ Corporation ”) ( TSXV: OTC) (OTCQB: OTCFF) (FRA:2QBO), a leader in vision enhancement technology, is pleased toannounce that its intraocular lenses are now being manufactured forthe upcoming first-in-human study in the Dominican Republic.
“We are thrilled to collaborate with Bioana,leveraging their medical device expertise and cutting-edgemanufacturing facilities to bring our innovative intraocular lenses tolife,” said Dean Burns, CEO of Ocumetics Technology Corp. “Producing these lenses is a critical milestone in our mission toprovide clear distance and near vision after cataractsurgery.”
The Ocumetics lenses promise groundbreakingenhancements to vision correction technology. Designed to provide excellent visual acuity at all distancesand improved quality of life for patients, these lenses are set to beevaluated in an upcoming first-in-human clinical study in theDominican Republic.
Bioana’s state-of-the-art design expertise,manufacturing capabilities and commitment to excellence alignperfectly with Ocumetics’ dedication to developing top-tieraccommodating intraocular lenses. The initial production run willsupport the clinical evaluation process, providing essential data toensure the safety and efficacy of the Ocumetics lens.
“We are honored to be selected by Ocumetics for thispivotal project,” said Adriana Torres COO and Chief Engineer atBioana, a premier design and development firm in Monterrey, Mexico. “Our team is excited to apply our extensive experience in medicaldevice manufacturing to help Ocumetics achieve their vision oftransforming eye care.”
The first-in-human study in the Dominican Republic is acrucial step toward bringing these innovative lenses to market. Thestudy will evaluate the performance of the Ocumetics lenses in aclinical setting, providing valuable data, as Ocumetics works toobtain regulatory clearance for its accommodating intraocularlenses.
For more information about Ocumetics Technology Corp.and our cutting-edge vision enhancement solutions, please visitOcumetics.com.
About Ocumetics
Ocumetics Technology Corp. ( TSXV: OTC) (OTCQB: OTCFF) (FRA: 2QBO)is a Canadian research and product development company that is dedicated to developing advanced visioncorrection solutions that enhance the quality of life for patients.Through innovative research and development, Ocumetics aims totransform the field of ophthalmology with state-of-the-art intraocularlenses and other vision-enhancing technologies.
Ocumetics is in the preclinical study stage of agame-changing technology for the ophthalmic industry. Ocumetics hasdeveloped an expandable intraocular lens that fits within the naturallens compartment of the eye potentially to eliminate the need forcorrective lenses. It is designed to allow the eye’s naturalmuscle activity to shift focus from distance to near.
About Bioana
Bioana is a leading design and development companybased in Monterrey, Mexico, specializing in the production of medicaldevices. With a strong commitment to quality and innovation, Bioanapartners with global companies to bring cutting-edge medical solutionsto market.
FOR FURTHER INFORMATION, PLEASECONTACT:
Dean Burns Dayton Marks
President and CEO Director
(817) 874-7564 (778) 347-2500
Neither the TSXVenture Exchange nor its Regulation Services Provider (as that term isdefined in the policies of the TSX Venture Exchange) acceptsresponsibility for the adequacy or accuracy of this release.
CAUTIONARY STATEMENT REGARDING FORWARD-LOOKINGINFORMATION: This news release includes certain “forward-lookingstatements” under applicable Canadian securities legislation. Forward-looking statements include, but are not limited to,statements with respect to the commencement, timing and scope of theresearch and development to be conducted by the Corporation mentionedabove. Forward-looking statements are necessarily based upon anumber of estimates and assumptions that, while considered reasonable,are subject to known and unknown risks, uncertainties, and otherfactors which may cause the actual results and future events to differmaterially from those expressed or implied by such forward-lookingstatements. Such factors include but are not limited to: operationalmatters, historical trends, current conditions and expected futuredevelopments, access to financing as well as other considerations thatare believed to be appropriate in the circumstances. There can be noassurance that such statements will prove to be accurate, as actualresults and future events could differ materially from thoseanticipated in such statements. Accordingly, readers should not placeundue reliance on forward-looking statements. The Corporationdisclaims any intention or obligation to update or revise anyforward-looking statements, whether as a result of new information,future events or otherwise, except as required by law.
Copyright (c) 2024 TheNewswire - All rights reserved.